India — Maharashtra Food and Drug Administration
Tracked across 5 events · 39 articles · First seen Jul 11, 2026 · Last active Aug 12, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: The regulator enforced public health measures by barring sale, seizing stock, and ordering recall of Cadila Pharmaceuticals' drugs due to deceptive branding.
Jul 11, 2026 · 8 articles
Regulatory
On August 7, 2026, the India — Maharashtra Food and Drug Administration (FDA) issued a comprehensive compliance order for all licensed blood centres and blood storage facilities across the state, the first such statewide order.…
Impact: Issued the comprehensive compliance order, strengthening its regulatory oversight and potentially enhancing its reputation for enforcing blood safety standards.
Aug 07, 2026 · 6 articles
Regulatory
The India — Bombay High Court criticized the India — Maharashtra Food and Drug Administration for its drastic action against Cadila Pharmaceuticals, which had banned the sale and distribution of certain medicines and seized stock…
Impact: The FDA was criticized by the India — Bombay High Court for its drastic and procedurally flawed actions. It agreed to revoke its orders against Cadila and follow due process, which may affect its enforcement credibility.
Aug 11, 2026 · 9 articles
Regulatory
The India — Maharashtra Food and Drug Administration (FDA) conducted a statewide inspection drive of 434 licensed Ayurvedic drug manufacturing establishments across India — Maharashtra, assessing compliance with the Drugs and Cosmetics Act, 1940, the…
Impact: The regulator conducted the inspections and enforcement actions, strengthening its oversight role and potentially enhancing public trust in its operations.
Aug 11, 2026 · 10 articles
Regulatory
The India — Bombay High Court directed Amazon — Amazon Retail India to hand over all expired and perished goods from its Bhiwandi warehouse to the India — Maharashtra Food and Drug Administration for scientific…
Impact: The FDA's enforcement actions are being scrutinized by the court, which criticized its approach. The agency must file an affidavit and oversee the disposal, but its credibility is somewhat challenged.
Aug 10, 2026 · 6 articles
100
India — Maharashtra Food and Drug Administration issued compliance orderMaharashtra FDA issues...
80
India — Maharashtra Food and Drug Administration barred sale Cadila PharmaceuticalsBombay HC rebukes FDA over...
80
India — Maharashtra Food and Drug Administration suspended operations Sir J.J. Metropolitan Blood CentreMaharashtra FDA issues...
80
India — Maharashtra Food and Drug Administration suspended operations Maya Blood CentreMaharashtra FDA issues...
80
India — Maharashtra Food and Drug Administration revoked orders Cadila PharmaceuticalsBombay HC rebukes FDA over...
70
India — Maharashtra Food and Drug Administration suspended licence Amazon — Amazon Retail IndiaBombay HC orders Amazon...
70
India — Maharashtra Food and Drug Administration cancelled licence Amazon — Amazon Retail IndiaBombay HC orders Amazon...
70
Cadila Pharmaceuticals challenged ban India — Maharashtra Food and Drug AdministrationBombay HC rebukes FDA over...
60
India — Bombay High Court directed affidavit India — Maharashtra Food and Drug AdministrationBombay HC orders Amazon...
60
Amazon — Amazon Retail India challenged suspension India — Maharashtra Food and Drug AdministrationBombay HC orders Amazon...
Tukaram Mundhe
commissioner
↔
India — Maharashtra Food and Drug Administration
Tukaram Mundhe serves as the Commissioner of the Maharashtra Food and Drug Admin
ERGEN INTELLIGENCE
Track India — Maharashtra Food and Drug Administration live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard